About the Program
After the grand success of the Uncontrolled Hypertension Colloquium 2.0, we are
excited to introduce Uncontrolled Hypertension Colloquium 3.0, a flagship program by
Pfizer, endorsed by the Association of Physicians of India (API). This edition builds upon
the foundation of clinical excellence, offering deeper insights and practical strategies to
enhance patient care and drive better health outcomes
The objective of this initiative is to optimize clinical strategies for managing uncontrolled
hypertension. The program features a well-balanced combination of a comprehensive talk
by an international expert, case presentations by Indian specialists, and an interactive
panel discussion—enhancing expertise through engaging learning.
To recognize participation, attendees will receive a certificate of participation from API.
We are excited to continue building a lasting and impactful partnership with you through
this initiative.
